SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Immix Biopharma, Inc. (IMMX)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
1
Latest Activity
Jan. 16, 2026
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jan. 16, 2026 CORRESP Neutral/Informational Moderate Immix Biopharma, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on January 9, 2026. They ar… Read Filing EDGAR
Jan. 16, 2026 UPLOAD Concern from SEC Moderate The SEC has communicated to Immix Biopharma, Inc. that they will not be reviewing the company's registration statement filed on January 9, 2026. The SEC has reminded the company t… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.